INMBINmune Bio, Inc.Mar 30, 2026Q4 2025
Read transcript →INmune Bio, Inc. (INMB) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$1.41
-4.42%
Mkt Cap $39.08M
INMBINmune Bio, Inc.Mar 30, 2026INMBINmune Bio, Inc.Oct 30, 2025Q3 2025
Read transcript →INMBINmune Bio, Inc.Aug 8, 2025Q2 2025
Read transcript →INMBINmune Bio, Inc.May 10, 2025Q1 2025
Read transcript →INMBINmune Bio, Inc.Mar 27, 2025Q4 2024
Read transcript →INMBINmune Bio, Inc.Oct 31, 2024Q3 2024
Read transcript →INMBINmune Bio, Inc.Aug 1, 2024Q2 2024
Read transcript →INMBINmune Bio, Inc.May 9, 2024Q1 2024
Read transcript →INMBINmune Bio, Inc.Mar 28, 2024Q4 2023
Read transcript →INMBINmune Bio, Inc.Nov 1, 2023Q3 2023
Read transcript →INMBINmune Bio, Inc.Aug 7, 2023Q2 2023
Read transcript →INMBINmune Bio, Inc.May 3, 2023Q1 2023
Read transcript →INMBINmune Bio, Inc.Mar 3, 2023Q4 2022
Read transcript →INMBINmune Bio, Inc.Nov 3, 2022Q3 2022
Read transcript →INMBINmune Bio, Inc.Aug 3, 2022Q2 2022
Read transcript →INMBINmune Bio, Inc.May 8, 2022Q1 2022
Read transcript →INMBINmune Bio, Inc.Mar 3, 2022Q4 2021
Read transcript →INMBINmune Bio, Inc.Nov 4, 2021Q3 2021
Read transcript →INMBINmune Bio, Inc.Aug 7, 2021Q2 2021
Read transcript →INMBINmune Bio, Inc.May 5, 2021Q1 2021
Read transcript →INMBINmune Bio, Inc.Mar 4, 2021Q4 2020
Read transcript →INMBINmune Bio, Inc.Nov 8, 2020Q3 2020
Read transcript →INMBINmune Bio, Inc.Aug 9, 2020Q2 2020
Read transcript →INMBINmune Bio, Inc.May 14, 2020Q1 2020
Read transcript →INMBINmune Bio, Inc.Mar 11, 2020Q4 2019
Read transcript →